KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Return on Assets: 2016-2025

Historic Return on Assets for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to 0.01%.

  • BeOne Medicines' Return on Assets rose 16.00% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 16.00%. This contributed to the annual value of -0.11% for FY2024, which is 5.00% up from last year.
  • BeOne Medicines' Return on Assets amounted to 0.01% in Q3 2025, which was up 133.63% from -0.03% recorded in Q2 2025.
  • BeOne Medicines' 5-year Return on Assets high stood at 0.01% for Q3 2025, and its period low was -0.34% during Q1 2023.
  • In the last 3 years, BeOne Medicines' Return on Assets had a median value of -0.14% in 2024 and averaged -0.14%.
  • Per our database at Business Quant, BeOne Medicines' Return on Assets declined by 12bps in 2022 and then climbed by 20bps in 2024.
  • Quarterly analysis of 5 years shows BeOne Medicines' Return on Assets stood at -0.21% in 2021, then dropped by 12bps to -0.33% in 2022, then increased by 17bps to -0.16% in 2023, then increased by 5bps to -0.11% in 2024, then grew by 16bps to 0.01% in 2025.
  • Its last three reported values are 0.01% in Q3 2025, -0.03% for Q2 2025, and -0.07% during Q1 2025.